Citation Impact
Citing Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Progress in the treatment of a neglected infectious disease: visceral leishmaniasis
2004
Treatment strategies underpinning the global programme to eliminate lymphatic filariasis
2005
Barriers to Free Antiretroviral Treatment Access for Female Sex Workers in Chennai, India
2009
In eHealth in India today, the nature of work, the challenges and the finances: an interview-based study
2014
Leishmaniasis
2018 Standout
Liposomes as delivery systems for antibiotics
2009
The role of liposomes in clinical nanomedicine development. What now? Now what?
2019 Standout
Species-Directed Therapy for Leishmaniasis in Returning Travellers: A Comprehensive Guide
2014
Harmless Herbs? A Review of the Recent Literature
1998 Standout
Herb-drug interactions
2000 Standout
The Risk–Benefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava
2002 Standout
Health Risks of Herbal Remedies
1995
Drug delivery systems: An updated review
2012
Lymphatic filariasis and onchocerciasis
2010 Standout
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
In vitro studies on liposomal amphotericin B obtained by supercritical carbon dioxide–mediated process
2007
Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis
2015
Cutaneous leishmaniasis
2007 Standout
Toxic Mechanisms of Five Heavy Metals: Mercury, Lead, Chromium, Cadmium, and Arsenic
2021 Standout
Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis
2008
Antituberculosis drugs: Ten years of research
2007
Herbal Medicinals
1998 Standout
Chemotherapy in the Treatment and Control of Leishmaniasis
2006
The Use of Complementary and Alternative Therapies to Treat Anxiety and Depression in the United States
2001 Standout
Anti-infective potential of natural products: How to develop a stronger in vitro ‘proof-of-concept’
2006 Standout
Pharmacies, self-medication and pharmaceutical marketing in Bombay, India
1998 Standout
Sequential assembly of the septal cell envelope prior to V snapping in Corynebacterium glutamicum
2019 StandoutNobel
Lead, Mercury, and Arsenic in US- and Indian-Manufactured Ayurvedic Medicines Sold via the Internet
2008
Designing hydrogels for controlled drug delivery
2016 Standout
Traditional Chinese medicine
2008 Standout
The trinity of COVID-19: immunity, inflammation and intervention
2020 Standout
Leishmaniasis– current chemotherapy and recent advances in the search for novel drugs
2003
Chemistry and Biological Activities of Flavonoids: An Overview
2013 Standout
Low level lead exposure and oxidative stress: Current opinions
2007
Comparison between liposomal formulations of amphotericin B
2016
Burden of HIV among female sex workers in low-income and middle-income countries: a systematic review and meta-analysis
2012 Standout
Herbal Medicines and Perioperative Care
2001 Standout
U.S. Food and Drug Administration Approval of AmBisome (Liposomal Amphotericin B) for Treatment of Visceral Leishmaniasis
1999
Albendazole for the control and elimination of lymphatic filariasis: systematic review
2005
Trends in Alternative Medicine Use in the United States, 1990-1997
1998 Standout
Control of Neglected Tropical Diseases
2007 Standout
Computer Modeling in Biotechnology
2008
Liposomal amphotericin B as a treatment for human leishmaniasis
2012
Oxidative Stress: Harms and Benefits for Human Health
2017 Standout
Heavy metals and living systems: An overview
2011 Standout
Leishmaniasis
1999 Standout
Essential oils: From extraction to encapsulation
2015 Standout
Potential medicinal plants for CNS disorders: an overview
2006
Treatment options for visceral leishmaniasis: a systematic review of clinical studies done in India, 1980–2004
2005
A Mechanistic Approach to Antiepileptic Drug Interactions
1998
Antimicrobial Activities and Phytochemical Profiles of Endemic Medicinal Plants of Mauritius
2005
Susceptibility testing of Candida albicans and Aspergillus species by a simple microtiter menadione-augmented 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay
1995
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Waste Mismanagement in Developing Countries: A Review of Global Issues
2019 Standout
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Biological Activities of Hydrazone Derivatives
2007 Standout
Albendazole for lymphatic filariasis
2005
Nanoencapsulation, Nano-guard for Pesticides: A New Window for Safe Application
2016 Standout
Human and Animal Dirofilariasis: the Emergence of a Zoonotic Mosaic
2012 Standout
SELF-PRESCRIBING BY WAY OF PHARMACIES IN THREE ASIAN DEVELOPING COUNTRIES
1986
Metal–Organic Frameworks for Water Harvesting from Air
2018 StandoutNobel
Decision aids for people facing health treatment or screening decisions
2017 Standout
Clinical and Experimental Advances in Treatment of Visceral Leishmaniasis
2001
Complementary/Alternative Medicine Use in a Comprehensive Cancer Center and the Implications for Oncology
2000 Standout
Advances in leishmaniasis
2005 Standout
Invasive Candidiasis
2015 Standout
Heavy Metals and Human Health: Mechanistic Insight into Toxicity and Counter Defense System of Antioxidants
2015 Standout
2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adultsa
2015 Standout
Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America
2010 Standout
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Coarse-Grained (Multiscale) Simulations in Studies of Biophysical and Chemical Systems
2011 StandoutNobel
Drug delivery and nanoparticles: Applications and hazards
2008 Standout
Aspergillus fumigatusand Aspergillosis
1999 Standout
The role of Fc–FcγR interactions in IgG-mediated microbial neutralization
2015
Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Narrative Review: The Promotion of Gabapentin: An Analysis of Internal Industry Documents
2006 Standout
The Anticancer, Antioxidant and Antimicrobial Properties of the Sesquiterpene β-Caryophyllene from the Essential Oil of Aquilaria crassna
2015 Standout
Nanoparticles in Drug Delivery and Environmental Exposure: Same Size, Same Risks?
2006
Macrofilaricidal Activity and Amelioration of Lymphatic Pathology in Bancroftian Filariasis after 3 Weeks of Doxycycline Followed by Single-Dose Diethylcarbamazine
2009
Carrier effects on biological activity of amphotericin B
1996
Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
2019 Standout
Drug Resistance in Leishmaniasis
2006 Standout
Improving waste segregation while reducing costs in a tertiary-care hospital in a lower–middle-income country in Central America
2013
Works of Nilima Kshirsagar being referenced
Phase I Pharmacokinetic Study of a New 3-Azinomethyl-Rifamycin (Rifametane) as Compared to Rifampicin
1999
Pharmacokinetics and tolerance of liposomal amphotericin B in patients
1993
Safety and pharmacokinetics of a human monoclonal antibody to rabies virus: A randomized, dose-escalation phase 1 study in adults
2012
Successful treatment of resistant visceral leishmaniasis with liposomal amphotericin B
1994
Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in India
2004
Dose-ranging studies on liposomal amphotericin B (L-AMP-LRC-1) in the treatment of visceral leishmaniasis
1999
The Use and Safety of Non-Allopathic Indian Medicines
2002
Analysis of a clinically important interaction between phenytoin and Shankhapushpi, an Ayurvedic preparation
1992
Successful treatment of disseminated candidiasis resistant to amphotericin B by liposomal amphotericin B: a case report
1993
Liposomal drug delivery system from laboratory to clinic.
2005
Successful Treatment of Antimony-Resistant Visceral Leishmaniasis with Liposomal Amphotericin B (L-AmpB-LRC) in a Child
1995
Report: Medical students for monitoring biomedical waste segregation practices — why and how? Experience from a medical college
2008
An Asian Perspective on Drug and Related Health Care Information
1983
Preclinical & pharmaceutical testing of liposomal amphotericin B.
1993